Article info

Download PDFPDF
A6.14 Dysregulations in the sphingolipid pathway in sle patients

Authors

  • A Checa 1Department of Medical Biochemistry and Biophysics, Bioanalytical Chemistry Research Laboratory in Inflammatory Metabolomics, Karolinska Institutet, S-171 77, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • H Idborg 2Department of Medicine, Rheumatology Unit, Karolinska Institutet, S-171 77, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • D Garcia Sar 1Department of Medical Biochemistry and Biophysics, Bioanalytical Chemistry Research Laboratory in Inflammatory Metabolomics, Karolinska Institutet, S-171 77, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • PJ Jakobsson 2Department of Medicine, Rheumatology Unit, Karolinska Institutet, S-171 77, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • CE Wheelock 1Department of Medical Biochemistry and Biophysics, Bioanalytical Chemistry Research Laboratory in Inflammatory Metabolomics, Karolinska Institutet, S-171 77, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • I Gunnarsson 2Department of Medicine, Rheumatology Unit, Karolinska Institutet, S-171 77, Stockholm, Sweden3Department of Medicine, Rheumatology Unit, Karolinska University Hospital, S-171 76, Stockholm, Sweden PubMed articlesGoogle scholar articles

Citation

Checa A, Idborg H, Sar DG, et al
A6.14 Dysregulations in the sphingolipid pathway in sle patients

Publication history

  • First published February 24, 2016.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.